8-K: Ingevity Reports Mixed 2023 Results Amidst Restructuring and Market Shifts

Ingevity Corporation announced its fourth quarter and full year 2023 financial results, marked by restructuring charges and varying performance across its business segments.

Summary

• Ingevity's Q4 2023 net sales decreased by 3.1% to $371.7 million compared to the prior year.
• The company reported a net loss of $116.8 million in Q4, including $107.5 million in restructuring charges.
• Adjusted EBITDA for Q4 was $61.8 million, with a margin of 16.6%.
• Full year 2023 net sales increased by 1.4% to $1.69 billion.
• The full year net loss was $5.4 million, which included $145.3 million in restructuring charges.
• Adjusted EBITDA for the full year was $396.8 million, with a margin of 23.5%.
• The company completed the shutdown of its DeRidder, LA crude tall oil refinery in early February 2024, with remaining assets to be shut down in the first half of the year.
• Ingevity has issued full year 2024 guidance for sales between $1.40 billion and $1.55 billion and adjusted EBITDA between $365 million and $390 million.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative due to the mixed results, restructuring charges, and net losses, balanced by strong performance in some segments and positive future guidance.

Positives

• Performance Materials segment achieved record sales and EBITDA, driven by increased auto production and hybrid vehicle popularity.
• Road Technologies business line experienced significant growth, including the integration of road markings.
• Advanced Polymer Technologies improved profitability despite lower demand, achieving record EBITDA.
• The company implemented significant cost savings actions.
• Ingevity has a strong focus on developing solutions for electric vehicles and bioplastics.

Negatives

• The company reported a net loss for both Q4 and the full year 2023.
• Performance Chemicals segment experienced a significant decrease in EBITDA due to higher raw material costs and lower volumes.
• Advanced Polymer Technologies segment saw a decrease in sales due to weak market conditions.
• The Industrial Specialties business line faced lower volumes and increased CTO costs.
• Restructuring charges significantly impacted the company's net income.

Risks

• The company faces uncertainties related to the global industrial recovery, which could impact the Advanced Polymer Technologies and Industrial Specialties business lines.
• There are risks associated with the limited supply of or increased cost of raw materials, particularly crude tall oil (CTO).
• The company is exposed to risks related to international sales and operations.
• Adverse conditions in the automotive market could impact the Performance Materials segment.
• The company is exposed to potential losses due to the resale of CTO at less than the purchase price.

Future Outlook

Ingevity anticipates full year 2024 sales between $1.40 billion and $1.55 billion and adjusted EBITDA between $365 million and $390 million, excluding the resale of excess CTO. The company expects strong growth in Performance Materials and Road Technologies, while 2024 will be a transitional year for Performance Chemicals.

Management Comments

• 2023 was a record year for Performance Materials driven by increased global auto production and the growing popularity of hybrid electric vehicles.
• The Road Technologies business line posted another strong year as the teams strategic focus on expanding technology adoption keeps driving steady growth.
• The global industrial slowdown negatively impacted volumes in Advanced Polymer Technologies and the Industrial Specialties business line, which also faced unprecedented increases in CTO costs.
• I remain confident that as we execute the growth strategy we shared last year, the strength we delivered in Performance Materials and Road Technologies will continue and our APT segment and Industrial Specialties business line are positioned for more profitable growth in less cyclical end markets.
• We continue to make progress in using alternative oleo feedstocks to reduce our reliance on CTO and offer a more diverse product portfolio for use in higher margin, less cyclical end markets.
• Our Performance Materials segment and Road Technologies business line have good momentum from last year and are positioned for strong growth going into 2024, and we have taken significant steps to accelerate the repositioning of our Performance Chemicals segment and reduce costs.
• While 2024 will be a transitional year for Performance Chemicals as we complete the execution of our repositioning strategy, we will continue to focus on higher-growth end markets like bioplastics in APT and expect another year of strong results in Performance Materials.

Industry Context

The results reflect a mixed performance in the specialty chemicals industry, with strong demand in automotive and infrastructure sectors contrasting with weakness in industrial markets. The company's focus on electric vehicles and bioplastics aligns with broader sustainability trends.

Comparison to Industry Standards

• Ingevity's Performance Materials segment, with a 48.9% EBITDA margin, outperforms many specialty chemical companies focused on automotive applications, such as Cabot Corporation (with margins typically in the 15-20% range) and Ashland (with margins in the 18-22% range).
• The Road Technologies business line's 53% sales growth is significantly higher than the average growth rate in the road construction materials sector, which is typically in the low single digits, indicating successful market penetration and technology adoption.
• The Performance Chemicals segment's struggles with higher CTO costs and lower volumes are similar to challenges faced by other companies in the oleochemicals sector, such as Kraton Corporation, which has also experienced volatility in raw material costs.
• The restructuring charges of $145.3 million are substantial and indicate a significant strategic shift, which is not uncommon in the chemical industry when companies need to adapt to changing market conditions, similar to restructuring efforts seen at companies like DuPont and Dow in recent years.
• The company's net debt ratio of 3.3x is within the typical range for companies in the specialty chemicals sector, but it is important to monitor this ratio given the ongoing restructuring and market uncertainties.

Stakeholder Impact

• Shareholders will be impacted by the net loss and restructuring charges, but may be encouraged by the strong performance in some segments and future guidance.
• Employees may be affected by the restructuring and workforce reductions.
• Customers may experience changes in product availability due to the repositioning of the Performance Chemicals segment.
• Suppliers may be impacted by changes in raw material sourcing and demand.
• Creditors will be monitoring the company's debt levels and financial performance.

Next Steps

• The company will complete the shutdown of the remaining assets of the DeRidder, LA refinery during the first half of 2024.
• Ingevity will continue to focus on higher-growth end markets like bioplastics in APT.
• The company will continue to execute its growth strategy and focus on maximizing profitability.

Key Dates

Keywords

Ingevity, Performance Materials, Performance Chemicals, Advanced Polymer Technologies, Road Technologies, Adjusted EBITDA, Restructuring, Crude Tall Oil, Automotive, Bioplastics